npj Regenerative Medicine

Scope & Guideline

Exploring Breakthroughs in Regenerative Science.

Introduction

Welcome to your portal for understanding npj Regenerative Medicine, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherNATURE PORTFOLIO
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationNPJ REGEN MED / npj Regen. Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

The journal 'npj Regenerative Medicine' focuses on advancing the field of regenerative medicine through the publication of high-quality research that explores the mechanisms, applications, and innovations in tissue repair and regeneration.
  1. Regenerative Mechanisms:
    The journal emphasizes the biological and molecular mechanisms underlying tissue regeneration, including cellular signaling pathways, stem cell biology, and the role of the extracellular matrix.
  2. Innovative Therapeutic Strategies:
    Research articles often highlight novel therapeutic interventions, including cell-based therapies, biomaterials, and bioengineering approaches aimed at enhancing regenerative outcomes.
  3. Translational Research:
    A significant focus is on the translation of laboratory findings into clinical applications, assessing the effectiveness of regenerative therapies in preclinical and clinical settings.
  4. Integrative Approaches:
    The journal encourages interdisciplinary research that combines insights from biology, engineering, and medicine to foster innovative solutions for complex regenerative challenges.
  5. Disease Models:
    Studies often utilize various disease models to investigate regeneration processes and therapeutic efficacy, providing insights into specific conditions such as heart disease, neurological disorders, and musculoskeletal injuries.
The journal 'npj Regenerative Medicine' is witnessing a dynamic shift towards several trending and emerging research themes that reflect the latest advancements in the field.
  1. Bioengineering and Biomaterials:
    There is a growing emphasis on the development of advanced biomaterials and bioengineering techniques, including 3D printing and smart hydrogels, to enhance tissue regeneration and repair.
  2. Immunomodulation Strategies:
    Recent studies increasingly focus on immunomodulation as a strategy to improve regenerative outcomes, exploring how immune responses can be harnessed or modulated for better healing.
  3. Cellular Reprogramming:
    Emerging research highlights the potential of cellular reprogramming techniques, such as direct conversion of somatic cells into functional progenitor cells, as a promising avenue for regenerative therapies.
  4. Microenvironment Engineering:
    A trend towards the engineering of the tissue microenvironment to promote regeneration is evident, with studies investigating how biochemical and mechanical cues can influence stem cell behavior.
  5. Personalized Medicine Approaches:
    The integration of personalized medicine into regenerative practices is gaining traction, with research focusing on tailoring therapies based on individual patient profiles and disease mechanisms.

Declining or Waning

While 'npj Regenerative Medicine' continues to explore a wide range of topics, certain themes appear to be declining in prominence as the field evolves.
  1. Traditional Stem Cell Therapies:
    There is a noticeable decrease in publications focused solely on traditional stem cell therapies without integration of advanced bioengineering or novel delivery systems.
  2. Invasive Surgical Techniques:
    Research related to invasive surgical techniques for tissue repair is becoming less frequent, with a shift towards less invasive, regenerative approaches such as biomaterials and scaffolds.
  3. Single-Cell Studies:
    Although single-cell analysis remains important, there has been a decline in studies focusing exclusively on single-cell genomics in the context of regeneration, as researchers increasingly adopt multi-omics approaches.
  4. Basic Mechanistic Studies:
    Publications that focus solely on basic mechanistic studies without direct translational relevance are becoming less common, as there is a stronger emphasis on applied research and clinical implications.
  5. Animal Models for Early-Stage Research:
    The reliance on animal models for early-stage research is waning in favor of human-relevant systems, including organoids and other advanced in vitro models.

Similar Journals

GROWTH FACTORS

Illuminating the path from research to clinical application.
Publisher: TAYLOR & FRANCIS LTDISSN: 0897-7194Frequency: 6 issues/year

GROWTH FACTORS, published by Taylor & Francis Ltd, is a prestigious journal dedicated to advancing the field of cell biology, clinical biochemistry, and endocrinology. With an ISSN of 0897-7194 and an E-ISSN of 1029-2292, this journal has served as a vital platform for the dissemination of groundbreaking research since its inception in 1988. Although it operates without an Open Access model, GROWTH FACTORS focuses on providing high-quality, peer-reviewed articles that explore the intricate roles of growth factors in biological processes and their implications in health and disease. Holding a Q4 ranking in Cell Biology and Q3 rankings in Clinical Biochemistry and Endocrinology according to the 2023 category quartiles, the journal is well-regarded in its field and plays a crucial role in informing researchers, professionals, and students alike about the latest findings and innovations in these areas. The journal's commitment to fostering scientific dialogue ensures that it remains a key resource for those looking to enhance their understanding of growth factors and their applications in clinical settings.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Elevating Knowledge in Biochemistry Since 1973
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

CELL AND TISSUE RESEARCH

Championing Quality Research in Histology and Cell Dynamics
Publisher: SPRINGERISSN: 0302-766XFrequency: 12 issues/year

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

JOURNAL OF CELLULAR PHYSIOLOGY

Transforming Cellular Research into Clinical Applications
Publisher: WILEYISSN: 0021-9541Frequency: 12 issues/year

JOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.

Inflammation and Regeneration

Empowering discoveries in inflammation and regenerative therapies.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

STEM CELLS

Innovating methodologies for transformative discoveries.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

CYTOTECHNOLOGY

Cultivating Discovery: Inspiring New Horizons in Bioengineering and Biotechnology.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Connecting Scientists to Transform Pathological Understanding
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

Stem Cells International

Innovating Tomorrow's Therapies Through Stem Cell Science
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Organogenesis

Advancing the Frontiers of Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.